Ideaya and Hengrui report promising data for DLL3-targeted cancer drug
Ideaya and Hengrui report promising data for DLL3-targeted cancer drug Source link
Ideaya and Hengrui report promising data for DLL3-targeted cancer drug Source link
Congressman Gerry Connolly (D-VA) questions witnesses during a House Committee on Oversight and Government Reform hearing titled “A Hearing with
Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug Source link
Austin, Texas, United States, May 1st, 2025, FinanceWire TransCode Therapeutics (NASDAQ: RNAZ) reported continued progress in its Phase 1a trial
Key Takeaways Cancer treatment costs could soar under a proposal by President Donald Trump to raise tariffs by 25% on